Global $3.67B Smart Inhalers Market, 2026: Key Industry Insights & Projections - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Apr 8, 2019--The “Global Smart Inhalers Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026” report has been added to ResearchAndMarkets.com’s offering.
The global smart inhalers market was valued at US$ 1,006.6 Mn in 2017 and is expected to reach US$ 3,674.6 Mn by 2026, expanding at a CAGR of 15.7% from 2018 to 2026.
According to the research findings of the World Health Organization (WHO), chronic obstructive pulmonary disease is responsible for 5% of global deaths annually. There is no permanent cure for chronic respiratory illness such as COPD, asthma, and bronchitis. Immediate symptomatic relief provided by respiratory inhalation is the best possible cure, hence smart inhalers possess impressive market growth in the near future due to excellent patient adherence and compliance to the treatment regimen.
Metered dose inhalers (MDIs) are reigning the type segment for smart inhalers market. Excellent PK/PD profile achieved during the drug delivery and increasing demand in geriatric patients suffering from chronic illness drive the metered dose inhalers market growth.
Dry powder inhalers have gained tremendous attraction in recent times due to the drug irritation and severe adverse effects caused by the propellants employed in MDIs. Nebulizers are widely employed in pediatric patients due to higher safety and efficacy associated with the drug delivery system.
Chronic obstructive pulmonary disease is currently leading the application segment for smart inhalers market. The rampant growth of smokers in developed countries and rising industrialization in developing nation has led to the rise of air pollution and exposure to occupational dust and fumes. Asthma will be the fastest growing market in the near future due to the rising prevalence of hereditary asthma in children and requires immediate symptomatic relief due to constriction of respiratory muscles.
In the present scenario, North America with a share of 38% is leading the regional segment for smart inhalers market. The key features that contribute towards its supremacy are rampant growth in tobacco smokers and domicile of major players such as Propeller Health, Cohero Health, 3M Healthcare etc.
Europe accounts for 29% market share, on account of the increasing number of pediatric patients suffering from asthma and strategic collaboration between pharmaceutical giants and software companies to provide a smart inhaler system.
The Asia Pacific with a market share of 20% will be the fastest growing regional segment during the forecast period on account of increasing geriatric patients suffering from chronic pulmonary illness and emergence of local players exerting stringent competition to western giants in smart inhalers market.
Companies in collaboration with pharmaceutical key players engaged in the development of smart inhalers are Amiko, Adherium Limited, Cohero Health, 3M Healthcare, Opko Health, Inc., Propeller Health, Philips Respironics, Sensirion AG, Teva Pharmaceutical Industries Limited and Vectura Group, Plc.
Key Market Movements
- An increasing number of geriatric patients suffering from chronic respiratory illness
- A significant increase in the number of tobacco smokers and rising air pollution
- A recent launch of innovative smart apps and wireless services to enhance drug delivery and patient compliance
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Scope
1.3. Research Methodology
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global Smart Inhalers Market Portraiture
2.2. Global Smart Inhalers Market, by Type, 2017 (US$ Mn)
2.3. Global Smart Inhalers Market, by Application, 2017 (US$ Mn)
2.4. Global Smart Inhalers Market, by Geography, 2017 (US$ Mn)
Chapter 3. Smart Inhalers Market: Dynamics and Future Outlook
3.1. Market Overview
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Smart Inhalers Market, by Key Players, 2017
Chapter 4. Global Smart Inhalers Market, by Type
4.2. Metered Dose Inhalers
4.3. Dry Powder Inhalers
Chapter 5. Global Smart Inhalers Market, by Application
5.2. Chronic Obstructive Pulmonary Disease (COPD)
Chapter 6. Global Smart Inhalers Market, by Geography
6.2. North America Smart Inhalers Market Analysis, 2016 - 2026
6.3. Europe Smart Inhalers Market Analysis, 2016 - 2026
6.4. Asia Pacific Smart Inhalers Market Analysis, 2016 - 2026
6.5. Latin America Smart Inhalers Market Analysis, 2016 - 2026
6.6. Middle East and Africa Smart Inhalers Market Analysis, 2016 - 2026
Chapter 7. Company Profiles
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Adherium Limited
7.3. Cohero Health
7.4. 3M Healthcare
7.5. Opko Health Inc.
7.6. Propeller Health
7.7. Philips Respironics
7.8. Sensirion AG
7.9. Teva Pharmaceutical Industries Ltd.
7.10. Vectura Group PLC
For more information about this report visit https://www.researchandmarkets.com/r/5h5zhf
View source version on businesswire.com:https://www.businesswire.com/news/home/20190408005447/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Inhalers and Nebulisers,Respiratory Devices
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 04/08/2019 08:35 AM/DISC: 04/08/2019 08:35 AM